CD79A and COVID-19: First, the percentages of all SARS-CoV-2 antigen-specific memory B cells were proportional to the severity of COVID-19, and the severe group consistently showed higher proportions of all IgM+, IgA+ and IgG+ memory B cells compared to the other groups.